Matinas BioPharma
MTNB
MTNB
57 hedge funds and large institutions have $13.6M invested in Matinas BioPharma in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
24% less capital invested
Capital invested by funds: $18M → $13.6M (-$4.38M)
Holders
57
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$120K | |
| 2 | +$88.8K | |
| 3 | +$88.2K | |
| 4 |
GRP
Global Retirement Partners
San Rafael,
California
|
+$69.5K |
| 5 |
VF
Virtu Financial
New York
|
+$58.9K |
Top Sellers
| 1 | -$781K | |
| 2 | -$63K | |
| 3 | -$50K | |
| 4 |
MA
MONECO Advisors
Fairfield,
Connecticut
|
-$19K |
| 5 |
GAA
Global Assets Advisory
Orlando,
Florida
|
-$14K |